# Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

> **NCT00884793** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 8 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** raltegravir
- **DRUG:** Study NNRTI
- **DRUG:** Study PI

## Key facts

- **NCT ID:** NCT00884793
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884793, "Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00884793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*